Indication
Macular Edema
30 clinical trials
25 products
3 drugs
Clinical trial
An Open-label, Single Group, Single-dose Clinical Study to Evaluate the Usability of the Pre-filled Syringe of SB11 in Subjects With Neovascular Age-Related Macular Degeneration or Macular Oedema Secondary to Retinal Vein OcclusionStatus: Completed, Estimated PCD: 2023-11-30
Product
SB11Product
FaricimabProduct
AfliberceptClinical trial
A Phase III, Multicenter, Randomized, Double-Masked, Active Comparator-Controlled Study to Evaluate the Efficacy and Safety of Faricimab in Patients With Macular Edema Secondary to Central Retinal or Hemiretinal Vein OcclusionStatus: Completed, Estimated PCD: 2022-08-09
Clinical trial
A Phase III, Multicenter, Randomized, Double-Masked, Active Comparator-Controlled Study to Evaluate the Efficacy and Safety of Faricimab in Patients With Macular Edema Secondary to Branch Retinal Vein OcclusionStatus: Completed, Estimated PCD: 2022-07-06
Clinical trial
Randomized, Double-blind, Parallel, Active Controlled Study to Compare Efficacy & Safety Between Ranibizumab 10mg/ml Injection of Incepta and Lucentis in Patients With Diabetic Macular Edema by ITV InjectionStatus: Recruiting, Estimated PCD: 2025-02-01
Product
RanibizumabProduct
LucentisProduct
DexamethasoneProduct
OZURDEXClinical trial
A 12-month, Open-label, Multicenter, Phase 4 Study to Evaluate the Efficacy and Safety of OZURDEX® Implant 700 µg (Dexamethasone) on Patients With Macular Edema Secondary to Retinal Vein Occlusion in China (YANGTZE Study)Status: Completed, Estimated PCD: 2021-09-26
Clinical trial
An Observational Study Program to Investigate the Effectiveness of Intravitreal Aflibercept in Diabetic Macular Edema and/or Macular Edema Secondary to Retinal Vein Occlusion in a Real World SettingStatus: Completed, Estimated PCD: 2021-09-14
Clinical trial
Evaluation of an Updated Dexamethasone Posterior Segment Drug Delivery System Applicator in Participants With Macular Edema Due to Retinal DiseasesStatus: Completed, Estimated PCD: 2022-02-09
Clinical trial
Assessing the Efficacy and Safety fo DEXTENZA, Sustained Release Dexamethasone 0.4 mg Insert(s) When Placed Within the Lower Eye Lid Canaliculus or Both the Upper and Lower Canaliculi for the Treatment of Pain, Inflammation, and Cystoid Macular Edema Following 27 Gauge Vitrectomy With Internal Limiting Membrane Peel for the Treatment of Retinal Edema Associated With Macular Pucker.Status: Recruiting, Estimated PCD: 2024-12-31
Clinical trial
Special Drug Use Investigation of EYLEA for Diabetic Macular EdemaStatus: Completed, Estimated PCD: 2019-04-26
Product
PrednisoneClinical trial
A Prospective, Randomized, Double-masked, Active Comparator-controlled, Multi-center, Two-arm, Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-301 Compared With Intravitreal Aflibercept in Participants With Visual Impairment Due to Treatment-naïve Macular Edema Secondary to Retinal Vein Occlusion (RVO)Status: Completed, Estimated PCD: 2022-06-20
Product
KSI-301Product
MS-553Clinical trial
A Multicenter, Open-label, Dose Escalation Study Assessing the Safety and Treatment Effects of MS-553 in Diabetic Retinopathy Patients With Central Involved Macular EdemaStatus: Recruiting, Estimated PCD: 2023-12-31
Product
MHU650Clinical trial
A First-in-human, Open-label, Single Ascending Dose Study to Assess Safety and Tolerability of Intravitreal MHU650 in Participants With Macular Edema From Diabetic Macular Edema (DME), Neovascular Age-related Macular Degeneration (nAMD), or Retinal Vein Occlusion (RVO)Status: Completed, Estimated PCD: 2022-05-24
Product
Episcleral CelecoxibClinical trial
Phase I Study of Sequestered Transscleral, Controlled-Release Celecoxib Delivered Via Episcleral Reservoir for Treatment of Macular Edema & Inflammatory Disorders of the Eye Posterior Pole Including Sclera, Choroid, Retina or VitreousStatus: Active (not recruiting), Estimated PCD: 2024-06-30
Product
Episcleral DexamethasoneClinical trial
Phase I Study of Sequestered Transscleral, Controlled-Release Dexamethasone Delivered Via Episcleral Reservoir for Treatment of Macular Edema & Inflammatory Disorders of the Eye Posterior Pole Including Sclera, Choroid, Retina or VitreousStatus: Active (not recruiting), Estimated PCD: 2024-09-30
Product
VEGF Trap-EyeClinical trial
A Randomized, Double Masked, Active Controlled, Phase III Study of the Efficacy and Safety of Repeated Doses of Intravitreal VEGF Trap-Eye in Subjects With Diabetic Macular EdemaStatus: Completed, Estimated PCD: 2013-06-03
Clinical trial
Longterm Efficiency and Safety of Intravitreal Injections With Bevacizumab in Patients With Neovascularisation or Macular EdemaStatus: Recruiting, Estimated PCD: 2024-12-31
Product
BevacizumabClinical trial
Evaluation of Diabetic or Uveitic Macular Edema After Injection of a Fluocinolone Acetonide (AcF) Implant 1 Month After the Last Dexamethasone (DXM) Implant: Evaluation at 3 YearsStatus: Recruiting, Estimated PCD: 2024-06-01
Product
ACFClinical trial
Resistant Diabetic Macular Edema and Suprachoroidal InjectionStatus: Not yet recruiting, Estimated PCD: 2024-12-01
Product
Triamcinolone AcetonideClinical trial
Traditional Chinese Medicine and Ranibizumab in the Treatment of Macular Cystoid Edema Associated With Retinal Vein Obstruction.Status: Recruiting, Estimated PCD: 2024-12-31
Product
Jueling Mingmu decoctionClinical trial
A Phase 2b, Prospective, Multicenter, Randomized, Double-Masked, Active-Controlled Study to Assess the Efficacy and Safety of Repeat Intravitreal Injections of Foselutoclax (UBX1325) in Patients With Diabetic Macular EdemaStatus: Recruiting, Estimated PCD: 2025-03-01
Clinical trial
Ultra-wide-field Fluorescein Angiography in Patients With Macular Edema Secondary to Retinal Vein OcclusionStatus: Recruiting, Estimated PCD: 2024-10-30
Product
foselutoclaxClinical trial
Effect of Topical Nepafenac in Macular Thickening Related to Pan-retinal PhotocoagulationStatus: Terminated, Estimated PCD: 2008-12-01
Product
NepafenacClinical trial
Phase 4 Comparison of the Effects of Bevacizumab Before vs After Pattern Panretinal PhotocoagulationStatus: Terminated, Estimated PCD: 2008-07-01
Drug
afatinibClinical trial
Macular Edema Ranibizumab v. Intravitreal Anti-inflammatory Therapy TrialStatus: Completed, Estimated PCD: 2021-10-27
Product
Intravitreal MethotrexateProduct
Intravitreal RanibizumabClinical trial
Investigator Initiated Observational Study of Intravitreal Aflibercept Injection in Subjects With Diabetic Macular Edema Previously Treated With Ranibizumab or BevacizumabStatus: Completed, Estimated PCD: 2020-12-01
Drug
afliberceptClinical trial
Prospective Non-randomised Exploratory Study to Assess the Safety and Efficacy of Aflibercept (Eylea) in Cystoid Macular Oedema (CMO) Associated With Retinitis Pigmentosa (RP)Status: Completed, Estimated PCD: 2017-10-01
Clinical trial
Efficacy and Safety of Intravitreal Triamcinolone as Treatment of the Diffuse Diabetic Macular EdemaStatus: Completed, Estimated PCD: 2009-07-01
Clinical trial
Prevention of Post-photocoagulation Macular Edema by Intravitreal Bevacizumab.Status: Withdrawn, Estimated PCD: 2008-12-01
Drug
AtezolizumabProduct
Intravitreal injectionClinical trial
Combined Treatment of Intravitreous Bevacizumab and Triamcinolone for the Treatment or Macular Edema Secondary to Central Retinal Vein OcclusionStatus: Terminated, Estimated PCD: 2007-06-01
Product
Bevacizumab + Triamcinolone